Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Breast Cancer Therapy - Findings from Virginia Commonwealth University, Department of Radiation Oncology advance knowledge in breast cancer therapy
Cancer Therapy - Data on cancer therapy published by researchers at Northwestern University
Carcinoma Therapy - New carcinoma therapy findings from Institute of Oncology, Department of Radiation Oncology described
Chemotherapy - Research from Hospital de Pediatria provide new insights into chemotherapy in children
Chemotherapy - Research on chemotherapy in children discussed by scientists at Hospital de Pediatria
Clinical Trial Research - Researchers at Chinese Academy of Sciences target clinical trial research
HIV/AIDS Vaccines - Research reports from Fred Hutchinson Cancer Research Center provide new insights into HIV/AIDS vaccines
Melanoma Therapy - University of Schleswig-Holstein, Department of Dermatology details research in melanoma therapy
Prostate Cancer Therapy - New findings from Mount Vernon Hospital in the area of prostate cancer therapy published
A.P. Pharma, Inc. - A.P. Pharma Announces Positive Phase 3 Results with APF530 in the Prevention of CINV
Advinus Therapeutics P Ltd. - Advinus Therapeutics P Ltd. and Ortho-McNeil-Janssen Pharmaceuticals, Inc. Establish Drug Discovery and Development Collaboration
Aeolus Pharmaceuticals, Inc. - Aeolus Pharmaceuticals Announces Initiation of Multiple Dose Study of AEOL 10150 in a Patient with ALS
Allergies - Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
Apthera, Inc. - Apthera Announces Optimal Dose and Schedule of NeuVax for Phase III Clinical Trial in Breast Cancer
Aptuit Inc. - Aptuit Launches Program to Accelerate Early Stage Drug Development
ArQule, Inc. - ArQule Achieves Clinical Milestone in MiT Trial with ARQ 197
Bipolar Disorder - Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
Bronchiectasis - ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
Cempra Pharmaceuticals, Inc. - Cempra Pharmaceuticals and Biovista Enter Agreement for Macrolide Clinical Trial Design Support Studies
Clinical Trial Research - Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
Columbia Laboratories, Inc. - Columbia Laboratories Reports Results from Phase II Clinical Trial of Vaginally-administered Lidocaine for Dysmenorrhea
Companies and Markets - Companies and Markets: "Innovative Clinical Trial Design and Management - Trends, success stories and impact upon research and development budgets" market report available now
Cystic Fibrosis - Transave, Inc. Secures $12.5 Million in New Financing
Drug Development - NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting
Emergent BioSolutions Inc. - Emergent BioSolutions Signs Contract with BARDA/NIAID, Valued at Up to $29.7 Million, to Fund Development of AV7909 - a Next Generation Anthrax Vaccine
Genentech, Inc. - Genentech, GlycArt and Roche Enter into Collaboration Agreement for Potential Cancer Therapy
Haemacure Corporation - Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
Headache and Migraine - TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for Tezampanel
Heart Failure - Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure
Hollis-Eden Pharmaceuticals, Inc. - Hollis-Eden Pharmaceuticals Presents Additional Positive Findings for APOPTONE HE3235 in Preclinical Models of Castration-Resistant Prostate Cancer
Idera Pharmaceuticals, Inc. - Idera Pharmaceuticals Announces Preliminary Data from Phase 2a Clinical Study of IMO-2055 Monotherapy in Renal Cell Carcinoma
Neuropathic Pain - Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I
pSivida Corp. - pSivida Release: Results from the Six-Month Interim Readout of the Human PK Iluvien Study
Psoriasis - Synvista Therapeutics Receives Approval to Begin Phase 2 Trial of Topical SYI-2074 in Psoriasis
Telormedix SA - Telormedix Raises 21 Mio CHF in Series a Financing
Tranzyme Pharma - Tranzyme Pharma Announces Positive Phase IIb Results with Its Ghrelin Agonist, TZP-101, for Postoperative Ileus POI
VGX Pharmaceuticals - VGX Pharmaceuticals Awarded $23.5 Million NIH Contract to Develop DNA-Based Preventive HIV Vaccine Delivered Via Electroporation
VGX Pharmaceuticals - VGX Pharmaceuticals Commences Follow-on Phase I Study for Novel Oral Anti-Inflammatory Drug Targeting Rheumatoid Arthritis and Type 1 Diabetes
ViroStatics, srl - Virostatics' President and CEO, Dr. Franco Lori, to address the 2nd World Conference on Magic Bullets Ehrlich II in Nurnberg, Germany
